Comparison of the Effect of Denosumab and Alendronate on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1359/jbmr.080910
Authors: Jacques P Brown, Richard L Prince, Chad Deal, Robert R Recker, Douglas P Kiel, Luiz H de Gregorio, Peyman Hadji, Lorenz C Hofbauer, Jose M Álvaro-Gracia, Huei Wang, Matthew Austin, Rachel B Wagman, Richard Newmark, Cesar Libanati, Javier San Martin, Henry G Bone
Institutions: Centre hospitalier universitaire de Québec, Centre hospitalier de l'Université Laval, Université Laval, The University of Western Australia, Sir Charles Gairdner Hospital, Cleveland Clinic, Creighton University, Harvard University, Hebrew SeniorLife, Philipps University of Marburg, Technische Universität Dresden, Hospital Universitario de La Princesa, Amgen (United States), Stanford Medicine, Stanford University
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4235168944